Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 103

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 103
---
    Dental 
    $2,318,993  
    $2,468,205  
    $(149,212)
  
    Medical 
     41,124  
     45,600  
     (4,476)
  
    Total sales, net 
    $2,360,117  
    $2,513,805  
    $(153,688)

Consolidated revenue for the three months ended September 30, 2025, was
approximately $2.4 million, compared to $2.5 million for the same period in 2024, representing a decrease of approximately $154,000, or
6%. The decline in total revenue was primarily attributable to lower international and e-commerce dental sales, partially offset by new
contributions from the Company’s re-entry into the China market and modest growth in institutional sales.

Revenue from Dental Service Organizations (DSOs), government agencies, and dental schools increased slightly to approximately $83,000
for the three months ended September 30, 2025, compared to $81,000 in the prior-year period, reflecting steady institutional demand.

E-commerce dental revenue totaled approximately $1.0 million for the three
months ended September 30, 2025, compared to $1.1 million for the same period in 2024, a decrease of approximately $105,000, or 9%. The
decline was primarily driven by reduced order volume from certain online distributors and the timing of promotional campaigns during the
quarter.

International dental revenue decreased to approximately $1.0 million in
the third quarter of 2025, compared to $1.2 million in the third quarter of 2024, a reduction of approximately $242,000, or 20%. The decrease
was largely the result of slower distributor purchasing activity in certain European markets, partially offset by resumed sales in China.

Sales in China for the three months ended September 30, 2025, were approximately
$200,000, compared to no sales in the same period of 2024. The increase reflects the Company’s successful efforts to reestablish
operations and distribution channels in the region following prior-year market disruptions.

Revenue from the medical segment totaled approximately $41,000 for the
three months ended September 30, 2025, compared to $47,000 in the same period of 2024, a decrease of approximately $6,000, or 13%. The
decline was primarily related to